The Role of Platelet Factor 4 in Local and Remote Tissue Damage in a Mouse Model of Mesenteric Ischemia/Reperfusion Injury by Lapchak, Peter H. et al.
 
The Role of Platelet Factor 4 in Local and Remote Tissue Damage
in a Mouse Model of Mesenteric Ischemia/Reperfusion Injury
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Lapchak, Peter H., Antonis Ioannou, Poonam Rani, Linda A.
Lieberman, Kazuhisa Yoshiya, Lakshmi Kannan, Jurandir J. Dalle
Lucca, M. Anna Kowalska, and George C. Tsokos. 2012. The role
of platelet factor 4 in local and remote tissue damage in a mouse
model of mesenteric ischemia/reperfusion injury. PLoS ONE 7(7):
e39934.
Published Version doi:10.1371/journal.pone.0039934
Accessed February 19, 2015 10:47:55 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10454589
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAThe Role of Platelet Factor 4 in Local and Remote Tissue
Damage in a Mouse Model of Mesenteric Ischemia/
Reperfusion Injury
Peter H. Lapchak
1, Antonis Ioannou
1*, Poonam Rani
1, Linda A. Lieberman
1, Kazuhisa Yoshiya
1,
Lakshmi Kannan
1, Jurandir J. Dalle Lucca
3, M. Anna Kowalska
2, George C. Tsokos
1*
1Rheumatology Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America, 2Department of Pediatrics,
University of Pennsylvania School of Medicine, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America, 3The United States Army Institute
of Surgical Research, San Antonio, Texas, United States of America
Abstract
The robust inflammatory response that occurs during ischemia reperfusion (IR) injury recruits factors from both the innate
and adaptive immune systems. However the contribution of platelets and their products such as Platelet Factor 4 (PF4;
CXCL4), during the pathogenesis of IR injury has not been thoroughly investigated. We show that a deficiency in PF4
protects mice from local and remote tissue damage after 30 minutes of mesenteric ischemia and 3 hours of reperfusion in
PF4-/- mice compared to control B6 mice. This protection was independent from Ig or complement deposition in the tissues.
However, neutrophil and monocyte infiltration were decreased in the lungs of PF4-/- mice compared with B6 control mice.
Platelet-depleted B6 mice transfused with platelets from PF4-/- mice displayed reduced tissue damage compared with
controls. In contrast, transfusion of B6 platelets into platelet depleted PF4-/- mice reconstituted damage in both intestine
and lung tissues. We also show that PF4 may modulate the release of IgA. Interestingly, we show that PF4 expression on
intestinal epithelial cells is increased after IR at both the mRNA and protein levels. In conclusion, these findings demonstrate
that may PF4 represent an important mediator of local and remote tissue damage.
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Introduction
Ischemia reperfusion (IR) injury is defined as tissue damage
occurring after a transient loss of blood supply and subsequent
return [1]. During this process an extensive activation of the
inflammatory response first locally and then to almost all remote
organs leading to tissue damage [2]. Complement activation,
natural Ig, neutrophils, T cells and other immune mediators have
been shown to play a significant role in this process [3–6].
It has been well documented that natural IgM antibodies, self-
reactive IgM antibodies and local complement activation are
necessary to induce tissue damage after IR injury [3,7–9]. In
contrast, there is little is known on the role of IgA in tissue damage
after IR injury. It has been reported, however, that although IgA is
a poor activator of complement due to its inability to bind C1q, it
can initiate complement activation via the alternate pathway [10].
Our group has recently showed that IgA deposition is increased
locally in the intestine and also remotely in the lung after
mesenteric IR injury in C57BL/6J mice [11]. Therefore, natural
IgM and mucosal IgA may initiate tissue injury using different but
overlapping complement activation pathways.
Platelets or platelet-derived factors have been shown to
modulate the inflammatory response in many clinical entities
including chronic and acute inflammatory responses in rheuma-
toid arthritis [12] systemic lupus erythematosus [13], inflammatory
bowel disease [14], vascular inflammation in graft rejection [15]
and more recently in ischemia reperfusion injury [16]. Platelets are
activated through their interaction with integrins [17]. Upon
activation, platelets release many different molecules, including the
chemokine CXCL4 or Platelet factor-4 (PF4), a 70-amino acid
protein that exists as a 150 KDa tetramer. PF4 comprises 2–3% of
the total platelet proteins and 25% of the total a ´-granule proteins
and is released during platelet activation [18–20]. PF4 inhibits
local antithrombin III activity by binding with high affinity to
heparin-like molecules thus promoting coagulation. PF4 is
involved in many other biological processes including promoting
survival of hematopoietic stem cells [21] and inhibiting prolifer-
ation of endothelial cells and fibroblasts [22]. More recently, it has
been shown that PF4 forms stable heterodimers with CCL5
(RANTES) resulting in a synergistically amplified ability to recruit
monocytes [23]. Importantly, it has been shown that during
inflammation PF4 is able to promote the adherence of neutrophils
onto endothelial cells, promote neutrophil exocytocis [24], and
supports the generation of reactive oxygen species and other pro-
inflammatory cytokines from monocytes [25,26,27] to maintain
the immune response.
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e39934The generation of both PF4 deficient mice (PF4-/-) on a B6
background and mice overexpressing human PF4 has shed light to
its central role in thrombus formation and atherosclerosis [19].
Importantly, PF4 deficient mice do not have bleeding diathesis
and their white and red blood cell counts and hematocrit levels are
within normal range. Moreover, introduction of a PF4 null locus,
into the ApoE-/- mouse, a well known model of atherosclerosis
reduced atherosclerotic lesion formation compared with control
mice, thus demonstrating the important role of PF4 in the
pathogenesis of atherosclerosis [28].
Here we report here that a deficiency in PF4 can mitigate tissue
injury in the intestine and lung following mesenteric IR injury.
Materials and Methods
Ethics Statement
All experiments were performed in accordance with the
guidelines and approval of the Institutional Animal Care and
Use Committee of the Beth Israel Deaconess Medical Center.
Mice
PF4-/- mice on a B6 background were generated as previously
reported [19], (Children’s Hospital of Philadelphia) and back-
crossed onto a C57BL/6J background (N.20). C57BL/6J were
purchased from The Jackson Laboratory (Bar Harbor, ME) and
housed in the animal research facility at the Beth Israel Deaconess
Medical Center (BIDMC) and allowed to acclimate for 7 days
prior to their use in experiments. Eight to twelve week old male
mice were used for all the experiments. All experiments were
performed with age-matched PF4-/- mice and C57BL/6J.
Ischemia Reperfusion Injury Protocol
Mice were randomly assigned to either sham or IR groups. was
used for anesthesia. Anesthesia was induced by intraperitoneal (IP)
administration of pentobarbital (72 mg/kg; Nembutal, Lundbeck
Inc., Deerfield, IL) and maintained thereafter with a 36 mg/kg
dose. Mice were subjected to IR injury as previously described
[11]. Briefly, a midline laparotomy was performed; the superior
mesenteric artery was identified, isolated, and clamped using a
small non-traumatic micro vascular clip. After 30 minutes the clip
was removed and the intestines were allowed to reperfuse for up to
3 hours. The sham group was subjected to the same surgical
intervention without artery occlusion. The laparotomy incision
was sutured, the mice resuscitated with 1.0 mL pre-warmed sterile
PBS subcutaneously and body temperature was maintained at
37uC for the duration of the experimental procedure. After 3
hours, mice were euthanized by carbon dioxide asphyxiation and
whole blood and tissues were harvested. Intestine was removed,
flushed with ice-cold PBS and 10% phosphate-buffered formalin.
The specimens were fixed in 10% phosphate-buffered formalin at
4uC overnight. Intact lungs and bronchial tree was isolated,
expanded with 200–300 mL of 10% phosphate-buffered formalin,
removed. and fixed overnight at 4uC in 10% phosphate-buffered
formalin. Whole blood was obtained from sham control mice and
mice that underwent mesenteric ischemia reperfusion by cardiac
puncture in to tubes containing 168 mM dipotassium EDTA.
Plasma was prepared and stored at 280uC for additional studies.
Platelet Depletion
Mice received a single IP injection of an affinity purified
endotoxin-free rabbit anti-mouse polyclonal antibody prepared
with commercially available rabbit anti-mouse platelet anti-sera
(Inter-Cell Technologies, Jupiter, FL) as described previously [29].
For experiments, C57BL/6J mice were depleted of platelets two
days prior to and ischemia reperfusion experiments and were
randomly assigned to either sham or mesenteric IR groups.
Platelet Isolation and Transfusion
Whole blood was collected into syringes containing acid citrate
dextrose by cardiac puncture and transferred to polypropylene
tubes. After centrifugation at 100 X g at room temperature, the
upper phase containing platelet rich plasma was removed and the
platelets pelleted and resuspended in Tyrodes’ buffer for transfu-
sion as described previously [30]. Platelet numbers were deter-
mined using Hemavet 850 (Drew Scientific, Farmington, CT).
Platelets were transfused into anesthetized platelet-depleted
recipient mice ten minutes prior to the start of experiments.
ELISA
Plasma samples from sham control mice and mice that
underwent mesenteric ischemia reperfusion were prepared and
used in the mouse CXCL4/PF4 ELISA (cat. # DY595, R&D
Systems, Inc., Minneapolis, MN) according to the manufacturer’s
specifications.
Ig Isotyping
Plasma samples from sham control mice and mice that
underwent mesenteric ischemia reperfusion were prepared and
used in the multiplex mouse Ig isotyping kit (cat. # MGAM-300,
Millipore, Inc., Minneapolis, MN) according to the manufacturer’s
specifications. The sensitivity/accuarcy of the kit is as follows:
IgG1 0.7 ng/mL/.IgG1 96%, IgG2a 0.4 ng/mL/.IgG2a 98%,
IgG2b 0.6 ng/mL/.IgG2b 85%, IgG3/.IgG3 76%, 0.8 ng/
mL, IgA 1.1 ng/mL/.IgA 100%, and IgM 0.5 ng/mL/.IgM
98%.
Real-time Quantitative Reverse Transcriptase-polymerase
Chain Reaction (RT-PCR)
Villi from the small intestine were isolated from the submucosa
by gentle scraping with a sterile microscope slide and lung tissues
were transferred to tubes containing TRIZOL reagent immedi-
ately after harvest and stored at 280uC until RNA purification.
Total RNA was isolated from small intestine and lung using
TRIZOL reagent (Invitrogen, Carlsbad, CA). cDNA was synthe-
sized using the high capacity cDNA reverse transcription kit
(Applied Biosystems, Carlsbad, CA) according to manufacturer’s
protocols. Real time RT-PCR was performed with LightCycler
480 System (Roche, South San Francisco, CA) using TaqMan
gene expression Master Mix and predesigned TaqMan probes for
mouse PF4 and GAPDH as recommended by Applied Biosystems.
The averaged cycle threshold values of each reaction derived from
the target gene, determined with LightCycler 480 System software
(Roche, South San Francisco, CA), and were normalized to
GAPDH levels. Cycle threshold values were used to calculate
relative mRNA expression by the A ¨A ¨Ct relative quantification
method.
Histology and Tissue Injury Scoring
Formalin-fixed intestine and lung tissues were processed and
embedded in paraffin for histological analysis. Intestine and lung
sections of 5–8 mm thickness were stained with hematoxylin and
eosin and subjected to histological scoring to evaluate tissue
damage. All histological analysis was performed in a blinded
manner.
For each intestinal section, 100 villi were graded using a 6-tiered
scale as described previously [31]. Briefly, a normal appearing
villus was assigned a score of 0 while villi demonstrating tip
PF4 and Mesenteric Ischemia/Reperfusion Injury
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Guggenheims’ spaces were scored as 2 and villi containing patchy
disruption of the epithelial cells were scored as 3. Villi
demonstrating exposed, intact lamina propria and sloughing of
epithelial cell were scored as 4. Villi demonstrating exuding lamina
propria were assigned a score of 5, and lastly, villi with
hemorrhage or denudation were scored as 6. Scoring of lungs
for alveolar and peri-luminal injury was calculated based on
Cooke’s method [32]. Ten to twenty fields at high power field
magnification (4006) were viewed for each lung section and
scored for alveolar infiltration on a 3-tiered scale. The following
calculation for alveolar scores was performed as follows: a score of
0 was given when no infiltrate was present; a score of 1 was given
when the infiltrate could be visualized easily only at 4006; when
infiltrates were readily visible, a score of 2 was assigned; and the
score for consolidation was 3. Similarly, each section was scored
for peri-luminal damage (airway or blood vessel) at 1006. The
calculation for peri-luminal scores was as follows: when there was
no infiltrate a score of 0 was assigned; when the infiltrate was
between 1 and 3 cell layers thick, the score was 1; for infiltrates
ranging from 4 to 10 cells layers thick; a score of 2 was assigned;
and infiltrates .10 cell layers thick were scored as 3. Based on the
overall involvement of the section, a severity score was calculated:
the severity score for 0–25% involvement was 1; a severity score of
2 was assigned for 25–50% involvement; and the severity score for
.50% involvement was 3. For calculation of the total lung injury
score, the means of alveolar and peri-luminal scores for each
section for summed up and multiplied by the severity score, which
gave a final score ranging from 0 to 18.
Immunohistochemistry
For Immunohistochemistry, formalin-fixed paraffin sections of
intestine and lung were subjected to rehydration and antigen
retrieval as described by the manufacturer (BD Biosciences,
Billerica, MA). After blocking with PBS+10% FCS for an hour,
the sections were incubated overnight with primary antibodies.
The following day, sections were washed and incubated with
secondary antibodies for 1 h. Stained sections were developed with
NovaRed (Vector Laboratories, Burlingame, CA) and counter-
stained with hematoxylin (Vector Laboratories, Burlingame, CA).
Appropriate isotype controls were used. For immunohistochemical
studies, the following reagents were used: affinity-purified rabbit,
rat and goat polyclonal antibody, rabbit anti-mouse C3 (B-9,Santa
Cruz Biotech, Santa Cruz, CA), goat anti-mouse IgA (Invitrogen,
Carlsbad, CA), goat anti-mouse IgG (Abcam, Cambridge, MA ),
goat anti-human PF4, peroxidase-conjugated affinity-purified
secondary antibodies to rabbit rat and goat immunoglobulin
(Jackson ImmunoResearch, West Grove, PA), rat monoclonal
anti-Neutrophil (ab2557, Abcam, Cambridge, MA) and rat
monoclonal anti-Monocyte (ab15636, Abcam, Cambridge, MA).
Neutrophil and Monocyte Infiltration Scoring
Sham control and experimental lung tissues stained for
monocytes or neutrophils as described in the Immunohistochem-
istry section above were scored for neutrophil and monocyte
infiltration. Positive staining cells were counted in 20 fields at
1006or 2006for total lung tissue and the average was calculated
and plotted.
Image Development
Prepared slides were viewed on a Nikon Eclipse 80 i micro-
scope, and images were taken using the Nikon DS-FiI digital
camera and saved as tiff files. Images were adjusted globally using
the adjustment feature in the RGB channel using Adobe
Photoshop CS2 (Adobe Systems, San Jose, CA).
Statistical Analysis
Data are presented as mean 6 SD. All data were subjected to
statistical analysis using GraphPad Prism 4.0 for Windows
software program (GraphPad Software, San Diego, CA). A
p#0.05 was considered significant using the student t test to
compare sham and IR groups.
Results
PF4 Deposition is Dramatically Increased in the Lung and
Intestine of B6 Mice after Mesenteric IR Injury
Because PF4 mediates adherence and pro-inflammatory func-
tions of neutrophils and monocytes and both cell types are
invariably present in damaged tissue after mesenteric IR injury [2]
we stained intestinal and lung tissue sections B6 mice that
undergone mesenteric IR injury with an anti-PF4 antibody. As
shown in figure 1A–F, abundant amount of PF4 is detected in the
lung vasculature and in the intestinal villi of B6 mice that
underwent mesenteric IR injury compared to sham-operated
mice. Furthermore, we found that PF4 deposition in the intestine
was limited to the intestinal epithelial cells of the villi. To exclude
the possibility that PF4 protein in the intestine was platelet-
associated and to verify that it was produced by IEC, we stained
for PF4 in intestine and lung tissue sections obtained from platelet
depleted mice that were either sham-treated or had undergone
mesenteric IR injury (Figure S1B, C). PF4 deposition in the lung
was reduced compared to sham and IR platelet-intact mice
(Figure 1 B, C). In the intestine, PF4 protein was detected in the
villi, was predominantly found at the tips (Figure S1E) and was
both more widespread and increased after mesenteric IR injury
(Figure S1F). Together, these findings suggest that intestinal
epithelial cells may be a novel source of PF4 and may play a role in
tissue damage following mesenteric IR injury.
Since we identified PF4 deposition in the villi of the small
intestine in sham-treated mice, and this deposition dramatically
increased after mesenteric IR injury, mRNA levels were deter-
mined from isolated villi and from lung by real time PCR. As
shown in figure 1H, mRNA levels obtained from isolated villi
increased in sham controls when compared to naı ¨ve (untreated)
mice (p#0.05) and this expression further increased after 30
minutes of ischemia and 120 minutes of reperfusion (p#0.01). In
contrast, there are no differences in mRNA levels in the lungs from
naı ¨ve mice, sham-treated mice or mice that underwent the
experimental procedure (Figure 1G).
Intestine and Lung Tissue Damage is Reduced in PF4-/-
Mice after Mesenteric IR Injury
To evaluate the role of PF4 in tissue damage, PF4 deficient mice
were subjected to mesenteric IR injury. As can be seen in
Figure 2A–H, lung and intestinal damage in PF4-/- was reduced
compared to wild type B6 control mice. Moreover, there was a
significant reduction in intestinal and lung injury scores compared
to B6 mice (Figure 2I, J). We verified that PF4 protein is absent in
PF42/2 mice under all experimental conditions as shown in
Figure 2K. In contrast, plasma PF4 levels were found in naı ¨ve
C57BL/6J mice and were significantly increased in both sham-
treated mice and mice that underwent mesenteric IR injury
(Figure 2K). This increase in plasma PF4 levels in both sham and
IR B6 mice may be attributed to platelet activation and release of
a ´-granules contents following mild trauma (midline laparotomy) or
major trauma (midline laparotomy and IR).
PF4 and Mesenteric Ischemia/Reperfusion Injury
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Reduced in the Lung of PF4-/- Mice after Mesenteric IR
Injury
PF4 has been reported to modulate the function of PMN and
monocytes [23–27]. To further evaluate the role of PF4 in IR
injury, intestine and lung sections were stained for PMN and
monocytes and these cells counted to determine increased
infiltration. We found that both PMN (Figure 3A–F) and MO
infiltration (Figure 3G–L) into lungs were reduced in PF4-/- mice
when compared to B6 mice. Cumulative data shown in
Figure 3 M, N suggest a trend lower but which did not reach
statistical significance. However, when we compared B6 mice that
underwent mesenteric IR compared to sham control mice, PMN
infiltration was significantly greater. In contrast, no differences
were observed in PMN and MO infiltration in the intestinal tissue
from both PF4-/- and B6 mice (Figure S2). This finding suggests
that PF4 may be partially involved in neutrophil and monocyte
recruitment into the lung leading to remote tissue damage after
mesenteric IR injury.
Complement and Immunoglobulin (Ig) Deposition in
PF4-/- Mice
It has been reported that complement and immunoglobulin (Ig)
deposition is associated with tissue damage after mesenteric IR
injury [3]. Therefore, we next examined the presence of comple-
ment and Ig in intestinal and lung tissue sections from PF4-/- mice
subjected to mesenteric IR injury. Surprisingly, we did not find
differences in complement (Figure 4A–L), IgM (Figure 5A–L) and
IgA(Figure5M–X)depositionbetweenPF4-/-andB6controlmice.
We conclude that in the PF4 deficient mice complement and Ig
Figure 1. PF4 deposition increased dramatically in the intestine and lung of B6 mice after mesenteric IR injury. Tissue sections of lung
(A-C) and intestine (D-F) from B6 after 30 minutes of mesenteric ischemia and 3 hrs of reperfusion were stained for PF4 (red) and counterstained with
hematoxylin (blue). Images are representative of 3–4 mice per group. (G) PF4 mRNA levels in lung. (H) PF4 mRNA levels in intestinal epithelial cells. All
images shown are 2006and 4006magnification. *p#0.05, **p#0.01, for IR compared to sham controls.
doi:10.1371/journal.pone.0039934.g001
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mesenteric IR injury and that additional components are required.
Next we addressed whether a deficiency in PF4 leads to altered
immunoglobulin production. Plasma samples from untreated,
sham and IR B6 and PF4-/- mice were subjected to multiplex
analysis. There were no significant differences in plasma levels of
total IgM (Figure 6A), IgA (Figure 6B) and IgG (Figure 6C) in
untreated naive C57BL/6J and PF4-/- mice. We next determined
plasma Ig (IgG, IgM and IgA) levels in sham control mice and in
mice that underwent mesenteric ischemia reperfusion. We found
no significant differences in total plasma IgM (Figure 6A) and IgG
(Figure 6C) in the sham control or mesenteric IR C57BL/6J and
PF4-/- mice. Surprisingly, we did find that plasma IgA levels in
PF4-/- sham control mice and mice that underwent mesenteric IR
injury were significantly increased (p#0.01 and p#0.05, respec-
tively) compared to their C57BL/6J experimental counterparts
(Figure 6A). These data suggest that PF4 may regulate IgA release
from IgA producing B lymphocytes in mucosal tissues.
Transfusion of PF4-/- Platelets into Platelet Depleted B6
Mice Fails to Restore Local and Remote Tissue Damage
after Mesenteric IR Injury
It is well known that PF4 is predominantly synthesized in
megakaryocytes and stored in platelet a ´-granules [17]. Accordingly
we asked whether platelet-derived PF4 accounts for the tissue
damage after mesenteric IR injury. We transfused purified
platelets from PF4-/- mice into platelet-depleted B6 mice and
performed mesenteric IR injury. Normal B6 and platelet-depleted
PF4-/- mice transfused with B6 platelets were used as controls.
Platelet-depleted B6 mice transfused with PF4-/- platelets
displayed reduced lung (Figure 7A–B) and intestinal (Figure 7H–
I) tissue damage. In contrast, transfusion of B6 platelets into
platelet depleted PF4-/- mice reconstituted a statistically signifi-
cant amount of damage in both lung (Figure 7C–F) and intestine
(Figure 7J–M). Cumulative data are shown in Figures 7G and
Figure 7N for lung and intestine respectively. In conclusion, these
experiments confirm that platelet-derived PF4 plays a definitive
role in the expression of remote tissue damage after mesenteric IR
injury.
Discussion
In this study we introduce a novel role for PF4 as a mediator of
remote lung injury after mesenteric IR injury. We first demon-
strate that intestinal epithelial cells (IEC) express low basal levels of
PF4 mRNA (and protein) in sham-treated mice and this expression
is dramatically increased after 120 min of reperfusion. In contrast
there was no increase in PF4 mRNA in lung under any
experimental condition. To our knowledge, there are no reports
in the literature describing PF4 expression in the gut (IEC) as it
was initially thought to be platelet specific, although it is now
documented that other immune cells also produce it, albeit at
much lower levels [33]. Furthermore, this is the first demonstra-
Figure 2. Intestinal and lung injury is reduced after mesenteric ischemia/reperfusion in PF4
-/- mice: Hematoxylin and eosin stained
sections of mouse small intestine and lung after 30 minutes of ischemia and 3 hours reperfusion. A total of 5–8 mice were used for each control and
experimental groups in two experiments. (A-D) Images of lung from sham and IR (E-H). Images of intestinal villi from sham and IR. All images shown
are 2006magnification. (I,J) Injury score (mean 6 SD) in lung and intestine.(K) PF4 plasma levels in B6 and PF4-/- mice before and after mesenteric IR
injury. *p#0.05, **p#0.01, and ***p#0.001 for IR compared to sham controls.
doi:10.1371/journal.pone.0039934.g002
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that PF4 mRNA expression and protein in the gut may be
important in gut homeostasis. PF4 combines with other chemo-
kines such as RANTES (CCL5), [23] and forms heterodimers.
These heterodimers lead to enhanced neutrophil and monocyte
chemoattraction. Hence, low levels of PF4 in combination with
other chemokines may constantly recruit leukocytes to the villi to
maintain barrier function. The increase in IEC PF4 protein and
mRNA after mesenteric IR injury may provide an alarm signal
and as mentioned, form heterodimers with other chemokines,
recruits neutrophils and monocytes to protect the host from
bacterial invasion due to the loss of barrier integrity.
Since PF4 in combination with RANTES (CCL5) has been
shown to recruit PMN and monocytes [23], we determined
whether there were differences in PMN and monocyte recruit-
ment in lung and intestine after mesenteric IR injury in B6 and
PF4-/- mice. We found that PMN numbers were significantly
increased in lung after IR injury in B6 mice. In contrast, there
were no significant differences in the numbers infiltrating PMN
in PF4-/- mice. Recently we published a report demonstrating a
role for platelets in remote lung injury following mesenteric IR
injury [16]. Platelet depleted mice were devoid of any remote
tissue damage, however, villi injury although reduced was still
significantly greater when compared to sham controls. Reconsti-
tution of platelet-depleted B6 mice re-established lung damage.
Because PF4 is a major a ´-granule product of platelets [17],
locally high levels of PF4 in the lung vasculature subsequent to
platelet stasis after mesenteric IR injury may result in a
chemokine gradient that is selective for recruiting PMN and
monocytes to this site. Once attracted to these sites, PF4 also
induces PMN and MO adherence to endothelial cells on the
vascular wall and their eventual diapedesis into the lung proper.
It has been shown by Woller et al that PF4 stimulates human
monocytes to release reactive oxygen species (ROS). ROS has
been shown to initiate endothelial cell apoptosis [27]. Therefore,
PF4-activated monocytes in the intestine and lung of mice after
IR could initiate endothelial cell apoptosis. In contrast, we
previously found minimal numbers of platelets in villi after injury
at any time point tested [16]. Locally produced PF4 by IEC at or
near the site of injury may be sufficient to recruit IgA producing
Figure 3. Neutrophil (PMN) and monocyte infiltration is reduced in the lung of PF4-/- mice after mesenteric IR injury. Tissue sections
of lung of B6 and PF4-/- mice after 30 minutes of mesenteric ischemia and 3 hrs of reperfusion and were stained for neutrophils (A-F, red) and
monocytes (G-L, red) and counterstained with hematoxylin (blue). A total of 5–8 mice were used for each control and experimental groups in two
experiments. (M) Neutrophil infiltration score, (N) Monocyte infiltration score. ns: not significant *p#0.05 for IR compared to sham controls. Red:
Positive Staining.
doi:10.1371/journal.pone.0039934.g003
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PLoS ONE | www.plosone.org 6 July 2012 | Volume 7 | Issue 7 | e39934Figure 4. Tissue damage in PF4-/- mice is not associated with complement deposition. Tissue sections of lung (A-F) and intestine (G-L)
from B6 and PF4-/- mice after 30 minutes of mesenteric ischemia and 3 hrs of reperfusion and were stained C3 complement factor (red) and
counterstained with hematoxylin (blue). Images are representative of 3–4 mice per group.
doi:10.1371/journal.pone.0039934.g004
Figure 5. Tissue damage in PF4-/- mice is not associated with immunoglobulin (Ig) deposition. Tissue sections of lung and intestine from
B6 and PF4-/- mice after 30 minutes of mesenteric ischemia and 3 hrs of reperfusion were stained for IgM (A-L, red) and IgA (M-X, red) and
counterstained with hematoxylin (blue). Images are representative of 3–4 mice per group. Red: Positive Staining.
doi:10.1371/journal.pone.0039934.g005
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PF4 in recruiting PMN to sites of remote injury. PF4 by itself
may exhibit limited chemotactic function, however, when
combined with RANTES (CCL5) to form heterodimers, is much
more potent. This may also be true for RANTES [34].
Moreover, activated platelets also release RANTES [34–38]
and it has been reported that RANTES is only minimally
effective in recruiting PMN and monocytes [34]. Thus our
findings demonstrate a positive interaction between PF4 and
RANTES and further positions PF4 as a critical mediator of
remote tissue damage following mesenteric IR injury. Additional
studies to investigate the role of RANTES alone or RAN-
TES:PF4 are particularly warranted. The inability of platelets
transfused from PF4-/- mice into platelet depleted B6 mice
further supports our claim for a role of PF4 in local and remote
tissue damage. As discussed above RANTES alone is only
minimally chemotactic for neutrophils and monocytes, however,
when combined with PF4 in heterodimers is a potent chemoat-
tractant.
We next show that PF4-/- mice are protected from intestinal
and lung tissue damage after mesenteric IR injury compared to
B6 mouse controls. A number of studies by other and us have
demonstrated a role for natural Ig in the injury process after
mesenteric IR [3,11]. We also sought to characterize in part, the
innate response in PF4-/- mice. Hence, we evaluated plasma Ig
levels, tissue bound Ig and complement deposition after
mesenteric IR injury. We demonstrate that PF4 deficiency does
not influence total Ig levels circulating in plasma or complement
deposition. We next looked at the long established IgM and our
recently reported IgA in mesenteric IR injury [11]. Surprisingly,
plasma IgA levels were significantly increased in PF4-/- mice
that were sham-treated and mice that underwent mesenteric IR
injury although levels were similar in naı ¨ve PF4-/- mice when
compared to B6 mice. These findings are novel since there has
been no demonstrable role for PF4 in modulating IgA
production. Since IgA exists as two separate immunoglobulin
types, secreted and membrane-associated [39], we postulate that
in the absence of PF4, there is an upregulation of secreted IgA
which might be protective. Our postulation is based on the fact
that there is reduced villi damage after mesenteric IR injury in
PF4-/- mice, yet IgA deposition is similar on villi compared to
that observed with B6 mice. Additional work will be necessary to
address the role of PF4 on IgA production and release. No
reports attribute a role for PF4 on B cell function, activation or
Ig release. However, it has been reported that there is differential
expression of chemokine receptors on human IgA+ and IgG+ B
lymphocytes [40] with both B cell subsets expressing CXCR3
and CCR5. Hence there may be differential effects of
RANTES:PF4 via CXCR3 and RANTES via CCR5 receptors.
However, this study was limited since IgG and IgA production in
response to these agonists were not determined. It is plausible
that PF4 (in combination with RANTES to form heterodimers)
may act as a chemokine to recruit IgA+ B lymphocytes to sites of
inflammation while RANTES alone may act as an inducer of
IgA release. Further studies are needed to demonstrate a link
between these chemokines and Ig release.
We demonstrate that PF4 may directly or indirectly participate
in remote tissue damage. We also describe a previously unknown
Figure 6. Immunoglobulin (Ig) plasma levels in B6 and PF4-/- mice before and after mesenteric IR injury. Plasma samples obtained from
B6 and PF4-/- mice before and after mesenteric IR injury were subjected to multiplex analysis. (A) IgM plasma levels. (B) IgA plasma levels, (C) IgG
plasma levels. ns: not significant *p#0.05, **p#0.01, and ***p#0.001 for IR compared to sham controls. A total of 5–8 mice were used for each
control and experimental groups in two experiments.
doi:10.1371/journal.pone.0039934.g006
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PF4 may directly or/indirectly alters IgA production. We next
wanted to demonstrate that platelet-derived PF4 is involved in
remote tissue damage. This was accomplished by transfusing
platelets from PF4-/- mice to platelet depleted B6 mice. This led to
significantly less lung damage and reduced intestine damage
compared to the B6 control mice, an observation we previously
made with mice depleted of platelets prior to mesenteric IR injury
[16]. In both cases, the levels of tissue damage were similar. More
importantly, transfusion of normal B6 platelets into platelet-
depleted PF4-/- mice re-established tissue damage in both the lung
and intestine. Hence PF4 either directly or indirectly through
heterodimer formation with RANTES is a necessary participant in
remote tissue damage. Release of PF4 from activated B6 platelets
in PF4-/- mice was sufficient to re-establish remote lung tissue
damage.
Increasing data support a central role for platelets and their
products in the pathogenesis of many inflammatory diseases [41–
44]. For example, in patients with systemic lupus erythematosus, it
has been demonstrated that platelets are activated by circulating
immune complexes and can modulate the recruitment of
monocytes contributing to the severity of the disease [13].
Similarly in rheumatoid arthritis, P-selectin expressed on activated
platelets regulates neutrophil recruitment at the site of inflamed
tissue, thus contributing to the tissue damage [12]. Platelet-derived
PF4 plays major role in endothelial proliferation and endothelial
cell apoptosis, angiogenesis [45], tumor development [46] and
atherosclerosis [19,27,28,47,48]. PF4 also has been found to
influence granulocyte activation by increasing neutrophil adher-
ence to endothelial cells, promoting the release of myeloperoxidase
and lysozyme from these cells [49], protecting monocytes from
spontaneous apoptosis [50] and affecting macrophage activation
and differentiation [19,51]. The regulation of these processes
grants PF4 an important role during the inflammatory response.
However the significance of this molecule and its biological
functions have not been evaluated during mesenteric IR injury
until know.
From this study, we propose a novel role for PF4 in the
expression of tissue damage during mesenteric IR injury. Based on
our findings we can suggest that PF4 is a potential therapeutic
target against tissue damage during mesenteric IR injury.
Figure 7. Transfusion of PF4-/- platelets into platelet depleted B6 mice fails to restore local and remote tissue damage after
mesenteric IR injury. Hematoxylin and eosin stained lung and small intestine sections of PF4-/- mice transfused with B6 platelets and vise versa
after 30 minutes of ischemia and 3 hours reperfusion. A total of 5–8 mice were used for each control and experimental groups in a total of two
experiments. (A-F) Images of lung from sham and IR. (H-M) Images of small intestine from sham and IR. All images shown are 2006magnification.
(G,N) Injury score (mean 6 SD) in lung and small intestine respectively. *p#0.05 and ***p#0.001 for IR compared to sham controls.
doi:10.1371/journal.pone.0039934.g007
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Figure S1 PF4 deposition in the lung and intestine of
platelet depleted B6 mice after mesenteric IR injury.
Tissue sections of lung (A-C) and intestine (D-F) from platelet-
depleted B6 after 30 minutes of mesenteric ischemia and 3 hrs of
reperfusion were stained for PF4 (red) and counterstained with
hematoxylin (blue). Images are representative of 3–4 mice per
group. All images shown are 2006and 4006magnification.
(TIF)
Figure S2 Neutrophil (PMN) and monocyte infiltration
in intestine of PF4-/- mice and B6 after mesenteric IR
injury. Tissue sections of intestine of B6 and PF4-/- mice after 30
minutes of mesenteric ischemia and 3 hrs of reperfusion and were
stained for neutrophils (A-F, red) and monocytes (G-L, red) and
counterstained with hematoxylin (blue). A total of 5–8 mice were
used for each control and experimental groups in two experiments.
All images shown are 2006and 4006magnification.
(TIF)
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